0000014272-18-000080.txt : 20180313 0000014272-18-000080.hdr.sgml : 20180313 20180313165507 ACCESSION NUMBER: 0000014272-18-000080 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180310 FILED AS OF DATE: 20180313 DATE AS OF CHANGE: 20180313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gordon Murdo CENTRAL INDEX KEY: 0001642156 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 18687148 MAIL ADDRESS: STREET 1: C/O BRISTOL-MYERS SQUIBB COMPANY STREET 2: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 4 1 wf-form4_152097449339050.xml FORM 4 X0306 4 2018-03-10 0 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001642156 Gordon Murdo BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 0 1 0 0 EVP, Chief Commercial Officer Common Stock, $0.10 par value 2018-03-10 4 M 0 1838 0 A 29805.605 D Common Stock, $0.10 par value 2018-03-10 4 J 0 417 0 A 30222.605 D Common Stock, $0.10 par value 2018-03-10 4 F 0 1111 67.92 D 29111.605 D Common Stock, $0.10 par value 2018-03-10 4 M 0 2455 0 A 31566.605 D Common Stock, $0.10 par value 2018-03-10 4 J 0 143 0 A 31709.605 D Common Stock, $0.10 par value 2018-03-10 4 F 0 1280 67.92 D 30429.605 D Common Stock, $0.10 par value 2018-03-10 4 M 0 3073 0 A 33502.605 D Common Stock, $0.10 par value 2018-03-10 4 J 0 131 0 A 33633.605 D Common Stock, $0.10 par value 2018-03-10 4 F 0 1578 67.92 D 32055.605 D Common Stock, $0.10 par value 2018-03-10 4 M 0 4722 0 A 36777.605 D Common Stock, $0.10 par value 2018-03-10 4 J 0 846 0 A 37623.605 D Common Stock, $0.10 par value 2018-03-10 4 F 0 2743 67.92 D 34880.605 D Common Stock, $0.10 par value 2018-03-10 4 M 0 27147 0 A 62027.605 D Common Stock, $0.10 par value 2018-03-10 4 F 0 13370 67.92 D 48657.605 D Market Share Units 2018-03-10 4 M 0 1838 0 D 2018-03-10 Common Stock, $0.10 par value 1838.0 0 D Market Share Units 2018-03-10 4 M 0 2455 0 D 2019-03-10 Common Stock, $0.10 par value 2455.0 2457 D Market Share Units 2018-03-10 4 M 0 3073 0 D 2020-03-10 Common Stock, $0.10 par value 3073.0 6146 D Market Share Units 2018-03-10 4 M 0 4722 0 D 2021-03-10 Common Stock, $0.10 par value 4722.0 14166 D Market Share Units 2018-03-10 4 A 0 13509 0 A 2022-03-10 Common Stock, $0.10 par value 13509.0 13509 D Performance Shares 2018-03-10 4 M 0 27147 0 D 2018-03-10 Common Stock, $0.10 par value 27147.0 0 D Performance Shares 2018-03-10 4 A 0 20264 0 A 2021-03-10 Common Stock, $0.10 par value 20264.0 20264 D Represents vesting of one-quarter of market share units granted on March 10, 2014. Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Shares withheld for payment of taxes upon vesting of awards. Represents vesting of one-quarter of market share units granted on March 10, 2015. Represents vesting of one-quarter of market share units granted on March 10, 2016. Represents vesting of one-quarter of market share units granted on March 10, 2017. Amount represents distribution of performance shares earned under the 2015-2017 Long-Term Performance Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board. Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. Each performance share converts into one share of common stock upon distribution in the first quarter of 2018, subject to a Total Shareholder Return modifier. Each performance share converts into one share of common stock upon distribution in the first quarter of 2021. EXHIBIT LIST: EX-24 Exhibit 24 - Murdo Gordon Power of Attorney /s/ Lisa A. Atkins, attorney-in-fact for Murdo Gordon 2018-03-13 EX-24 2 ex-24.htm EXHIBIT 24 - MURDO GORDON POWER OF ATTORNEY

POWER OF ATTORNEY




    I, Murdo Gordon, Executive Vice President and Chief Commercial Officer at Bristol-
Myers Squibb Company (the "Company"),  a corporation duly organized and existing under the
laws of the State of Delaware, in the United States of America, and having its principal place of
business at 345 Park Avenue, New York, New York, do hereby constitute and appoint each of
Sandra Leung, Katherine R. Kelly, Yun Jung Choi and Lisa A. Atkins, individually, as my
lawful attorney-in-fact and in my name, place and stead to execute and deliver any and all
documents relating to insider reporting requirements under Section 16 of the Securities Exchange
Act of 1934 with respect to securities issued by the Company, including, without limitation, the
execution and filing of all Forms 3, 4 and 5, and to take such other action, as such attorney
considers necessary or appropriate, to effectuate such transactions.  This Power of Attorney shall
remain in full force and effect until I am no longer required to file Forms 3, 4, and 5 with respect
to securities issued by the Company, unless earlier revoked.

    IN WITNESS WHEREOF, I have executed this Power of Attorney on this 26th day of
January, 2018.



    /s/ Murdo Gordon
                              Murdo Gordon